A prospective, time-series design, multicenter study on the effect of telmisartan on intra-renal RAS in type 2 diabetes.
Phase of Trial: Phase IV
Latest Information Update: 03 Nov 2016
At a glance
- Drugs Telmisartan (Primary)
- Indications Diabetic nephropathies
- Focus Pharmacodynamics
- 02 Nov 2016 Status changed from recruiting to completed.
- 06 Apr 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.
- 15 Apr 2009 New trial record.